|
|
Name: |
Cormorant Asset Management LLC |
City: |
BOSTON |
State: |
MA |
Zip: |
02110 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
56 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
MLTX |
Multisys Language Solutions... |
1 |
- |
$0.00 |
$512,962,000 |
8,494,151 |
24.56% |
48,862,000 |
352,051 |
20.669 |
N/A |
|
AMAM |
Ambrx Biopharma Adr Represe... |
2 |
- |
$0.00 |
$159,929,000 |
11,231,000 |
7.66% |
45,807,000 |
1,307,311 |
12.479 |
N/A |
|
EYPT |
EyePoint Pharmaceuticals Inc |
3 |
- |
$0.44 |
$139,544,000 |
6,038,235 |
6.68% |
113,976,000 |
2,838,235 |
4.207 |
Biotechnology |
|
BBIO |
Bridgebio Pharma, Inc. |
4 |
- |
$24.33 |
$135,005,000 |
3,344,179 |
6.46% |
12,054,000 |
-1,318,351 |
2.099 |
N/A |
|
ACLX |
Arcellx, Inc. |
5 |
- |
$0.00 |
$94,350,000 |
1,700,000 |
4.52% |
17,208,000 |
-450,000 |
3.471 |
N/A |
|
RYZB |
Rayzebio, Inc. |
6 |
- |
$62.49 |
$75,442,000 |
1,213,478 |
3.61% |
49,196,000 |
31,215 |
1.996 |
N/A |
|
BMEA |
Biomea Fusion, Inc. |
7 |
- |
$10.47 |
$51,849,000 |
3,570,872 |
2.48% |
2,714,000 |
0 |
12.412 |
N/A |
|
IMVT |
Immunovant Inc |
8 |
- |
$0.00 |
$49,081,000 |
1,165,000 |
2.35% |
2,053,000 |
-60,000 |
1.338 |
N/A |
|
ALPN |
Alpine Immune Sciences Inc |
9 |
- |
$64.62 |
$48,603,000 |
2,550,000 |
2.33% |
26,848,000 |
650,000 |
5.554 |
N/A |
|
PHVS |
Pharvaris N V Ord Shs |
10 |
- |
$0.00 |
$48,006,000 |
1,711,460 |
2.3% |
19,592,000 |
350,000 |
5.166 |
N/A |
|
ALXO |
Alx Oncology Holdings Inc |
11 |
- |
$0.00 |
$46,786,000 |
3,142,079 |
2.24% |
43,848,000 |
2,530,000 |
6.307 |
N/A |
|
TARS |
Tarsus Pharmaceuticals, Inc. |
12 |
- |
$0.00 |
$44,984,000 |
2,221,422 |
2.15% |
-1,599,000 |
-400,000 |
8.329 |
N/A |
|
CBAY |
Cymabay Therapeutics, Inc. |
13 |
- |
$32.48 |
$42,516,000 |
1,800,000 |
2.04% |
-14,888,000 |
-2,050,000 |
1.9 |
N/A |
|
PCVX |
Vaxcyte, Inc. |
14 |
- |
$0.00 |
$41,762,000 |
665,000 |
2% |
7,860,000 |
0 |
0.617 |
N/A |
|
CRNX |
Crinetics Pharmaceuticals, ... |
15 |
- |
$42.29 |
$40,917,000 |
1,150,000 |
1.96% |
8,146,000 |
48,096 |
1.982 |
N/A |
|
APLS |
Apellis Pharmaceuticals Inc |
16 |
- |
$47.93 |
$37,413,000 |
625,000 |
1.79% |
-38,667,000 |
-1,375,000 |
0.546 |
N/A |
|
MRNS |
Marinus Pharmaceuticals Inc |
17 |
- |
$1.42 |
$35,328,000 |
3,250,000 |
1.69% |
14,197,000 |
625,000 |
6.55 |
N/A |
|
AUTL |
Autolus Therapeutics Plc |
18 |
- |
$4.08 |
$35,098,000 |
5,450,000 |
1.68% |
34,184,000 |
5,057,833 |
3.149 |
N/A |
|
OLMA |
Olema Pharmaceuticals, Inc. |
19 |
- |
$0.00 |
$34,469,000 |
2,456,800 |
1.65% |
-21,165,000 |
-2,047,964 |
6.116 |
N/A |
|
IMRX |
Immuneering Corp |
20 |
- |
$0.00 |
$30,902,000 |
4,204,364 |
1.48% |
-1,388,000 |
0 |
16.208 |
N/A |
|
EWTX |
Edgewise Therapeutics, Inc. |
21 |
- |
$0.00 |
$27,919,000 |
2,551,989 |
1.34% |
11,033,000 |
-394,898 |
3.656 |
N/A |
|
AVTE |
Aerovate Therapeutics, Inc. |
22 |
- |
$0.00 |
$27,421,000 |
1,211,696 |
1.31% |
6,229,000 |
-350,000 |
4.571 |
N/A |
|
CRGX |
Cargo Therapeutics, Inc. |
23 |
New |
$0.00 |
$27,376,000 |
1,182,563 |
1.31% |
27,376,000 |
1,182,563 |
0 |
N/A |
|
SNDX |
Syndax Pharmaceuticals Inc |
24 |
New |
$20.57 |
$25,392,000 |
1,175,000 |
1.22% |
25,392,000 |
1,175,000 |
1.531 |
N/A |
|
KRRO |
Korro Bio |
25 |
New |
$0.00 |
$25,363,000 |
529,170 |
1.21% |
25,363,000 |
529,170 |
1.573 |
N/A |
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
26 |
- |
$38.15 |
$25,284,000 |
550,000 |
1.21% |
5,798,000 |
-300,000 |
0.896 |
N/A |
|
HARP |
Harpoon Therapeutics, Inc. |
27 |
- |
$0.89 |
$22,551,000 |
2,349,060 |
1.08% |
22,333,000 |
2,295,000 |
7.19 |
N/A |
|
AGLE |
Aeglea Biotherapeutics, Inc. |
28 |
New |
$0.60 |
$20,166,000 |
937,080 |
0.97% |
20,166,000 |
937,080 |
1.532 |
N/A |
|
INSM |
Insmed Inc |
29 |
- |
$24.92 |
$17,819,000 |
575,000 |
0.85% |
3,300,000 |
0 |
0.379 |
Biotechnology |
|
IDYA |
Ideaya Biosciences, Inc. |
30 |
- |
$0.00 |
$16,011,000 |
450,000 |
0.77% |
-177,000 |
-150,000 |
0.935 |
N/A |
|
AXNX |
Axonics Modulation Technolo... |
31 |
- |
$66.54 |
$15,558,000 |
250,000 |
0.74% |
1,528,000 |
0 |
0.473 |
N/A |
|
NGNE |
Neurogene |
32 |
New |
$3.68 |
$14,461,000 |
746,180 |
0.69% |
14,461,000 |
746,180 |
1.781 |
N/A |
|
LBPH |
Longboard Pharmaceuticals, ... |
33 |
- |
$0.00 |
$14,189,000 |
2,353,141 |
0.68% |
1,106,000 |
0 |
13.908 |
N/A |
|
PRAX |
Praxis Precision Medicines,... |
34 |
- |
$0.00 |
$14,111,000 |
633,345 |
0.68% |
-2,134,000 |
-8,866,655 |
1.209 |
N/A |
|
RCKT |
Rocket Pharmaceuticals |
35 |
- |
$22.10 |
$13,487,000 |
450,000 |
0.65% |
4,266,000 |
0 |
0.572 |
N/A |
|
RAPT |
Rapt Therapeutics, Inc. |
36 |
- |
$7.80 |
$12,344,000 |
496,750 |
0.59% |
6,942,000 |
171,750 |
1.376 |
N/A |
|
IRON |
Disc Medicine, Inc |
37 |
- |
$26.52 |
$7,220,000 |
125,000 |
0.35% |
-3,351,000 |
-100,000 |
0.718 |
N/A |
|
STOK |
Stoke Therapeutics, Inc. |
38 |
- |
$0.00 |
$5,722,000 |
1,087,807 |
0.27% |
1,436,000 |
0 |
2.286 |
N/A |
|
VERV |
Verve Therapeutics, Inc. |
39 |
- |
$0.00 |
$4,879,000 |
350,000 |
0.23% |
238,000 |
0 |
0.527 |
N/A |
|
LNTH |
Lantheus Holdings, Inc. |
40 |
New |
$65.20 |
$4,650,000 |
75,000 |
0.22% |
4,650,000 |
75,000 |
0.104 |
N/A |
|
CNTA |
Centessa Pharmaceuticals Plc |
41 |
- |
$0.00 |
$4,470,000 |
561,600 |
0.21% |
836,000 |
0 |
0.642 |
N/A |
|
BHVN |
Biohaven Ltd. |
42 |
- |
$38.54 |
$3,508,000 |
81,963 |
0.17% |
1,376,000 |
0 |
0.12 |
N/A |
|
GHRS |
Gh Research Ord Shs |
43 |
- |
$0.00 |
$3,440,000 |
593,043 |
0.16% |
-2,520,000 |
0 |
1.214 |
N/A |
|
VYNE |
VYNE Therapeutics Inc |
44 |
New |
$0.22 |
$3,249,000 |
1,394,336 |
0.16% |
3,249,000 |
1,394,336 |
2.716 |
N/A |
|
BCAB |
Bioatla, Inc. |
45 |
- |
$0.00 |
$2,906,000 |
1,181,115 |
0.14% |
898,000 |
0 |
2.562 |
N/A |
|
NMRA |
Neumora Therapeutics, Inc. |
46 |
- |
$9.06 |
$1,574,000 |
92,293 |
0.08% |
272,000 |
0 |
0.06 |
N/A |
|
CABA |
Cabaletta Bio, Inc. |
48 |
Closed |
$0.00 |
$0 |
0 |
0% |
-43,825,000 |
-2,879,424 |
0 |
N/A |
|
ZNTL |
Zentalis Pharmaceuticals, Llc |
55 |
Closed |
$0.00 |
$0 |
0 |
0% |
-14,042,000 |
-700,000 |
0 |
N/A |
|
KRTX |
Karuna Therapeutics, Inc. |
54 |
Closed |
$0.00 |
$0 |
0 |
0% |
-23,673,000 |
-140,000 |
0 |
N/A |
|
ELVN |
Enliven Therapeutics Ord Shs |
47 |
Closed |
$0.00 |
$0 |
0 |
0% |
-16,620,000 |
-1,216,712 |
0 |
N/A |
|
VIGL |
Vigil Neuroscience, Inc. |
53 |
Closed |
$0.00 |
$0 |
0 |
0% |
-3,324,000 |
-616,786 |
0 |
N/A |
|
ERAS |
Erasca, Inc. |
52 |
Closed |
$1.88 |
$0 |
0 |
0% |
-21,302,000 |
-10,813,246 |
0 |
N/A |
|
RNA |
Avidity Biosciences, Inc. |
51 |
Closed |
$23.83 |
$0 |
0 |
0% |
-11,242,000 |
-1,762,115 |
0 |
N/A |
|
GPCR |
Structure Therapeutics Inc. |
50 |
Closed |
$38.98 |
$0 |
0 |
0% |
-53,262,000 |
-1,056,373 |
0 |
N/A |
|
COGT |
Cogent Biosciences, Inc. |
49 |
Closed |
$6.01 |
$0 |
0 |
0% |
-9,750,000 |
-1,000,000 |
0 |
N/A |
|
ORTX |
Orchard Therapeutics Plc |
56 |
Closed |
$0.00 |
$0 |
0 |
0% |
-198,000 |
-25,664 |
0 |
N/A |
|